Takeda, Lilly Jury Awards $9 Billion Over Actos Cancer Risks
April 9th, 2014Via: Bloomberg:
Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.
